George Demetri Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

George Demetri is of Blueprint Medicines Corp. Currently has a direct ownership of 8,412 shares of BPMC, which is worth approximately $725,955. The most recent transaction as insider was on Jun 21, 2022, when has been sold 2,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.41K
0% 3M change
0% 12M change
Total Value Held $725,955

George Demetri Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2022
BUY
Grant, award, or other acquisition
-
2,600 Added 23.61%
8,412 Common Stock
Mar 17 2022
SELL
Open market or private sale
$586 $58.56 p/Share
10 Reduced 0.17%
5,812 Common Stock
Jul 13 2021
BUY
Open market or private purchase
$827 $82.66 p/Share
10 Added 0.17%
5,822 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
2,250 Added 27.91%
5,812 Common Stock
Jan 04 2021
SELL
Open market or private sale
$85,010 $112.15 p/Share
758 Reduced 17.55%
3,562 Common Stock

Also insider at

TBIO
Translate Bio, Inc. Healthcare
Director
GD

George Demetri

Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC